1-3 of 3
Malik Faheem, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Access to Initial Treatment Was Not the Driving Force of the Survival Disparity By Insurance Status in Follicular Lymphoma — an Analysis of the National Cancer Database (NCDB)

Free
Ning Dong, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Malik Faheem, MD, Shanthi Srinivas, MD, Victor T. Chang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4155.
https://doi.org/10.1182/blood-2018-99-120111
Published: 2018
Journal Articles

Outcomes, Toxicities, and Patterns of Use of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Multicenter Retrospective Study

Free
Steven M. Bair, MD, Lauren Elizabeth Strelec, BA, Tatyana A Feldman, MD, Nirav N Shah, MD, Nishitha Reddy, MD MSCI, MBBS, Nadia Khan, MD, Charalambos Andreadis, MD MSCE, Chaitra S. Ujjani, MD, Arun K Singavi, MD, Christina Howlett, PharmD, Khoan Vu, MD, Malik Faheem, MD, Matthew R. Youngman, BS, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Anthony R. Mato, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4091.
https://doi.org/10.1182/blood.V130.Suppl_1.4091.4091
Published: 2017
Journal Articles

In-Hospital Mortality Among Patients with Multiple Myeloma in the United States: A 13-Year Perspective

Free
Jieqi Liu, Sejal Kothadia, MD, Malik Faheem, MD, David H. Vesole, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5652.
https://doi.org/10.1182/blood.V130.Suppl_1.5652.5652
Published: 2017